Mission Statement
| About | Funding | Mission Statement |Surgery and Molecular Oncology is committed to maintaining and developing excellence in basic scientific and clinical research while promoting the translation of basic research findings into clinical practice. The Department is also committed to the delivery of high quality undergraduate and postgraduate teaching, and to the delivery of the highest possible standard of clinical care. This is described in the following seven-point plan:
1. Maintain and develop excellence in basic scientific research into stress-response pathways with particular focus on their roles in cancer.
2. Promote translational research by interactions between interested scientists and clinicians using the tumour bank as the main resource. The main emphases will be on individualising cancer treatment on the basis of molecular genetic and proteomic profiling and on screening and diagnostics.
3. Maintain and develop excellence in research into surgical technology and to facilitate the transition of this activity into a wider Institute of Advanced Medical Technology and Bioengineering.
4. Foster interaction between surgical technology and molecular oncology to develop methods of introducing intact molecules into cells with therapeutic intent.
5. Increase the level of clinical research in surgery and oncology and promote the entry of patients into trials of locally-developed novel therapies.
6. Maintain and develop excellence in undergraduate and postgraduate teaching in surgery and molecular oncology by means of current practice and the development of Masters courses.
7. Maintain and develop the clinical service to the people of Tayside and Scotland in the following areas: colorectal, breast, hepato-pancreatico-biliary and upper gastrointestinal surgery.
Surgery and Molecular Oncology will also strive towards improved income generation by means of:
a) Overhead-bearing grants.
b) Collaborations with industry.
c) Taught postgraduate courses.
d) Fundraising.